Most powerful obesity drug yet: People lost up to 25% of weight in trial
Retatrutide is a triple-hormone obesity drug simulating GLP-1, GIP, and glucagon.
Ars Technica2 min read
1 story
Retatrutide is a triple-hormone obesity drug simulating GLP-1, GIP, and glucagon.
Showing 1 of 1 stories
You're all caught up.
Get the top AI news and tools straight to your inbox every week.
Weekly · AI news
Join 15,000+ AI enthusiasts